Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
nanofenretinide
cancer
Life Science
Drug Delivery
phospholipid
fenretinide
investment
bioavailability
SciTech
small cell lung cancer
combination
Immunotherapy
standalone
ST-001
drug
lymphoma
t-cell
partnering
SDP
Funding rounds raised
Total raised
$2.7M
from 3 investors over 3 rounds
S
SciTech Development LLC raised $2.7M on June 7, 2023
Investors: National Foundation for Cancer Research, Pointe Angels and Storm Lake Capital